Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:charity
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Bufotenin
|
| gptkbp:affects |
psychoactive
|
| gptkbp:defines |
gptkb:bufotenin
|
| gptkbp:developed_by |
serotonin
|
| https://www.w3.org/2000/01/rdf-schema#label |
5-HO-DMT
|
| gptkbp:ingredients |
C10 H12 N2 O
|
| gptkbp:legal_issue |
varies by country
|
| gptkbp:occurs_in |
gptkb:toads
|
| gptkbp:previous_name |
2-(1 H-indol-3-yl)-N, N-dimethyl-ethanamine
|
| gptkbp:products |
gptkb:DMT
|
| gptkbp:used_in |
psychedelic research
|